GI
AGMB

GAMMA Investing’s AgomAb Therapeutics NV AGMB Stock Holding History

GAMMA Investing’s Portfolio AGMB Stock Details AGMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4K Buy
+1,344
New +$15.1K ﹤0.01% 2912

Other funds holding AGMB

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

GAMMA Investing's AGMB Position: Q2 2026 in Review

GAMMA Investing opened a new position in AgomAb Therapeutics NV (AGMB) in Q2 2026: 1,344 shares worth $17.4K. The stake represents ﹤0.01% of the portfolio and ranks #2912 among its holdings.

4 funds tracked by Wall St. Rank hold AGMB as of Q2 2026.

  • GAMMA Investing held 1,344 shares of AgomAb Therapeutics NV worth $17.4K as of Q2 2026.
  • AgomAb Therapeutics NV was a new GAMMA Investing position in Q2 2026.
  • AgomAb Therapeutics NV made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2912 holding.
  • 4 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.